The doctor won't see you now: Survey shows pullback from in-person rep meetings, rise of omnichannel
Are your sales reps finding it harder to see doctors? A survey of physicians in major European markets suggests that may be the case, providing fresh evidence that meetings have become trickier to ...
Is the benefit to your medical group of maintaining ongoing relationships with pharma reps worth the cost? That’s a question confronting thousands of hospitals and medical groups today. Many factors ...
In yet another behind-the-scenes look at the drug industry, a former drug rep and a researcher who studies pharma marketing have published research outlining the pharma sales strategies. The article, ...
Nearly 60% of physicians say disease-specific leadership and corporate reputation are the most influential factors regarding which medicine they choose to prescribe to patients. The latest Brands in ...
Physicians appear to be restricting their contact with pharmaceutical representatives, according to recent data from Capgemini Consulting, the strategy and transformation brand of Paris-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results